F-2-CCG-I

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameF-2-CCG-I
Drug Alias Namemetabotropic glutamate receptor stimulator (Tokyo Metro)F-2-CCG-I
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor modulators
TargetsMetabotropic glutamate receptor
Therapy Area/IndicationsNerve DegenerationCraniocerebral TraumaEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTokyo Metropolitan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTokyo Metropolitan University
Active IndicationsN/A
Inactive IndicationsNerve DegenerationCraniocerebral TraumaEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A